1- CONTEXT
12-13 April 2021 African Vaccine Manufacturing Summit
The African Union Commission (AUC) and Africa Centres for Disease Control (Africa CDC) hosted a two-day high-level Summit under the theme “Expanding Africa’s Vaccine Manufacturing for Health Security: Building back better, bolder and bigger”. Amongst the continental leadership in attendance were:
• H.E Moussa Faki Mahamat, Chairperson, African Union Commission;
• H.E Félix Antoine Tshisekedi Tshilombo, Chairperson, African Union, President, Democratic Republic of the Congo;
• H.E Cyril Matamela Ramaphosa, African Union Champion for COVID-19 and President, South Africa and
• H.E Paul Kagame, President, Republic of Rwanda and Chairperson, AUDA-NEPAD.
Over 40,000 people attended via Zoom, YouTube, and Facebook, hearing from more than 70 expert panelists. Major outcomes arising from the high-level Summit were:
- A commitment to developing a detailed “Framework for Action” with key milestones on the way to reaching 60% local manufacturing of Africa’s routine vaccine needs by 2040
- The launch of the Partnerships for African Vaccine Manufacturing (PAVM)
- The live, virtual signing of two Memorandums of Understanding (MoUs) between the African Union and CEPI, and Afreximbank and the Africa Finance Corporation.
You can find the post-summit communique by clicking on the following link – communique
OBJECTIVES
i. Update on progress made so far on the Partnerships for African Vaccine Manufacturing in Africa
ii. Agree on an AU-endorsed approach to facilitate regulatory approval of vaccines produced in Africa
iii. Discuss critical market shaping needs once African countries produce vaccines
iv. Build on the momentum of vaccine manufacture hubs and pilot a drug API-final drug product Hub program